Suchergebnisse - "Patil, Tejas"

PubPharm (67)

1

Mesothelioma : Pleural, Version 1.2024

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2024

von Stevenson, J. | Ettinger, D. | Wood, D. | +42

2

The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC

enthalten in: JTO clinical and research reports | 2024

von Patil, T. | Staley, A. | Nie, Y. | +19

3

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC : A Multicenter Retrospective Cohort Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Nassar, A. | Kim, S. | Aredo, J. | +54

4

Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas

enthalten in: Cancer | 2023

von Kummar, S. | Shen, L. | Hong, D. | +21

CommentIn: Cancer. 2023 Dec 1;129(23):3694-3696. - PMID 37769119

5

Prediction of cancer treatment response from histopathology images through imputed transcriptomics

enthalten in: bioRxiv.org | 2023

von Hoang, D. | Dinstag, G. | Hermida, L. | +27

6

Prediction of cancer treatment response from histopathology images through imputed transcriptomics

enthalten in: Research square | 2023

von Hoang, D. | Dinstag, G. | Hermida, L. | +27

7

Mesothelioma : Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2023

von Ettinger, D. | Wood, D. | Stevenson, J. | +40

8

Exceptional response to lorlatinib and cabozantinib in ROS1-rearranged NSCLC with acquired F2004V and L2086F resistance

enthalten in: NPJ precision oncology | 2023

von Sakamoto, M. | Patil, T.

9

Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Grant, M. | Aredo, J. | Starrett, J. | +18

CommentIn: Transl Lung Cancer Res. 2024 Jan 31;13(1):195-198. - PMID 38404992

10

A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer

enthalten in: Clinical lung cancer | 2023

von Iams, W. | Balbach, M. | Phillips, S. | +15

1
2
3
4
5
6
7
Nächster »
[7]